While positive airway pressure (PAP) is effective in keeping the upper airway open during sleep in individuals with moderate to severe OSA, about 30% to 50% of patients will discontinue PAP within the first year due to the cumbersome and uncomfortable nature of the device
For example: Ozempic and Mounjaro may be covered when prescribed for Type 2 diabetes management Wegovy may be covered to reduce the risk of cardiovascular death, heart attack, or stroke in adults with established cardiovascular disease who are overweight or obese Zepbound may be covered for moderate to severe obstructive sleep apnea in adults with obesity Coverage for these approved indications depends on your specific Part D plan's formulary
Rodgers RJ, Tschp MH, Wilding JP
Moitra M, Santomauro D, Collins PY, Vos T, Whiteford H, Saxena S, et al
CJC-1295 appears to be a synthetic analog made of the first 29 amino acids from the GHRH sequence, which has additional modifications, including the replacement of four amino acids in its structure and the attachment of a Drug Affinity Complex (DAC) to potentially extend the pharmacokinetics of the peptide
